Project to Update the Study of Congenital Haemophilia in Spain (PUCHS)

Novo Nordisk

Status: Completed

Conditions: Haemophilia B; Haemophilia A; Congenital Bleeding Disorder

Treatments: Other: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT01959555

U1111-1136-7052 (Other Identifier)

NOV-HEM-2013-01 (Other Identifier)

HAEM-4076

Details and patient eligibility

About

This study is conducted in Europe. The aim of the study is to update the knowledge about the prevalence and severity of congenital haemophilia (A and B) in Spain.

Enrollment: 1,157 patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

• Informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol)
• Male patients of any age diagnosed with congenital haemophilia A or B who visited their HTC at least once during the period of January 2013 to December 2013

Exclusion criteria

• Previous participation in this study
• Female patients
• Acquired haemophilia

Trial design

1,157 participants in 1 patient group

Retrospective collection of data

Treatment:

Other: No treatment given